Norlis Life Sciences Private Limited
About Norlis Life Sciences Private Limited
Data last updated:
Norlis Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC365314.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Asmita Prashant Dangat and Rajneesh Barsati Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wing Vikhroli Park Site Veer Savarkar Marg Kailash Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.76 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹6.15 Lakh (net margin 3.5%) and EBITDA of ₹10.47 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address316 3rd Flr J(C) Wing Vikhroli Park Site Veer Savarkar Marg Kailash Business Park Vikh, Roli(W), Mumbai, Maharashtra, India – 400079
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Norlis Life Sciences Private Limited
The main business activity of Norlis Life Sciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Norlis Life Sciences Private Limited FY 2025 filings available
Norlis Life Sciences Private Limited reported revenue of ₹1.76 Cr (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Norlis Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 55% over three years, including 32% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Norlis Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.47 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.15 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Norlis Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6% | •••• | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Norlis Life Sciences are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Norlis Life Sciences Private Limited
Norlis Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other professional, scientific and technical activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lindinger Inspection Services Private Limited | ₹1.76 Cr (FY 2018) | •••• | •••• | 4.0% | •••• | Navi Mumbai, Maharashtra, India |
| Xieno E-Services Private Limited | ₹1.76 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Jaipur, Rajasthan, India |
| Formac Software Services Private Limited | ₹1.76 Cr (FY 2022) | •••• | •••• | -19.0% | •••• | Bengaluru, Karnataka, India |
| Blendnet Tech Solutions Private Limited | ₹1.76 Cr (FY 2024) | •••• | •••• | 609.0% | •••• | Bangalore, Karnataka, India |
| Revere Infotech India Private Limited | ₹1.76 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Bhopal, Madhya Pradesh, India |
| Norlis Life Sciences Private Limited this company | ₹1.76 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Mumbai, Maharashtra, India |
| Howard Technologies India Private Limited | ₹1.76 Cr (FY 2021) | •••• | •••• | 1152.0% | •••• | Khujra, Uttar Pradesh, India |
| Ats Interior Private Limited | ₹1.76 Cr (FY 2025) | •••• | •••• | -63.0% | •••• | Noida, Uttar Pradesh, India |
| Ant Studio Private Limited | ₹1.75 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Gurgaon, Haryana, India |
| Dhruva Powertronics Private Limited | ₹1.75 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Ratnagiri, Maharashtra, India |
| Pangolin Marketing Private Limited | ₹1.75 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Norlis Life Sciences by revenue in the same principal business activity (Other professional, scientific and technical activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Norlis Life Sciences Private Limited
Norlis Life Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asmita Prashant Dangat | Director | 05 Aug 2021 | 5 Years 2 Months | Current |
| Rajneesh Barsati Jaiswal | Director | 05 Aug 2021 | 5 Years 2 Months | Current |
| Prashant Narayan Dalvi | Director | 31 Aug 2021 | 5 Years 1 Months | Current |
| Mayur Manohar Gangurde | Director | 31 Aug 2021 | 5 Years 1 Months | Current |
Charges & Borrowings of Norlis Life Sciences Private Limited
Norlis Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Norlis Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Norlis Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Norlis Life Sciences Private Limited
Norlis Life Sciences Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Mayur Manohar Gangurde was appointed as Director on 31 Aug 2021.
Credit Ratings, Litigation & Regulatory Alerts for Norlis Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Norlis Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Norlis Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Norlis Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Norlis Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Norlis Life Sciences Private Limited
Norlis Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 August 2021 (5+ years old) and is registered under CIN U24299MH2021PTC365314.
Norlis Life Sciences reported revenue of ₹1.76 Cr for FY 2025 (up 32% YoY).
Norlis Life Sciences has 4 current directors:
- Asmita Prashant Dangat - Director
- Rajneesh Barsati Jaiswal - Director
- Prashant Narayan Dalvi - Director
- Mayur Manohar Gangurde - Director
Norlis Life Sciences reported a net profit of ₹6.15 Lakh (net margin 3.5%) and EBITDA of ₹10.47 Lakh (EBITDA margin 6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Norlis Life Sciences is 55% over three years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Norlis Life Sciences is U24299MH2021PTC365314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Norlis Life Sciences was incorporated on 05 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Norlis Life Sciences by revenue are Lindinger Inspection Services Private Limited, Xieno E-Services Private Limited, Formac Software Services Private Limited, Blendnet Tech Solutions Private Limited, Revere Infotech India Private Limited and 5 more, all in the same principal business activity (Other professional, scientific and technical activities).
Mayur Manohar Gangurde was appointed as Director on 31 Aug 2021. Prashant Narayan Dalvi was appointed as Director on 31 Aug 2021. Asmita Prashant Dangat was appointed as Director on 05 Aug 2021. Norlis Life Sciences has 4 board changes on record in total.
Yes, Norlis Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Norlis Life Sciences is at 316 3rd Flr JC Wing Vikhroli Park Site Veer Savarkar Marg Kailash Business Park Vikh, RoliW, Mumbai, Maharashtra, India – 400079.